The Obesity Profile offered by MedEX Neo Clinic is a comprehensive set of tests designed to assess various parameters related to obesity and associated health risks. This profile aims to thoroughly evaluate an individual's metabolic health and identify potential underlying factors contributing to obesity.
The profile includes a Blood Glucose Level test, measuring the amount of glucose in the bloodstream. Elevated blood glucose levels can indicate impaired glucose metabolism, insulin resistance, or diabetes, commonly associated with obesity.
Thyroid Function Tests are included in the Obesity Profile to evaluate the functioning of the thyroid gland. Thyroid imbalances can contribute to weight gain or hinder weight loss efforts. By measuring thyroid hormone levels, such as TSH (Thyroid-Stimulating Hormone), FT3 (Free Triiodothyronine), and FT4 (Free Thyroxine), this test helps identify any thyroid dysfunction that may be influencing weight management.
The profile also incorporates lipid profile tests, including Total Cholesterol, Triglycerides, HDL (High-Density Lipoprotein) Cholesterol, and LDL (Low-Density Lipoprotein) Cholesterol. These tests help assess an individual's cholesterol levels and lipid profile. Elevated total cholesterol, triglycerides, and LDL cholesterol, along with low HDL cholesterol levels, are commonly associated with obesity and can increase the risk of cardiovascular diseases.
SG PT/ALT (Serum Glutamate Pyruvate Transaminase) and SGOT/AST (Serum Glutamate Oxaloacetate Transaminase) tests are included to assess liver health. Obesity can contribute to non-alcoholic fatty liver disease (NAFLD) and liver dysfunction. Elevated levels of these enzymes can indicate liver damage or inflammation.
The Obesity Profile includes tests for CPK (Creatine Phosphokinase) and CPK-MB (Creatine Phosphokinase-MB), enzymes released into the bloodstream during muscle damage or injury. Obesity can stress the musculoskeletal system, leading to muscle damage or strain. Measuring these enzyme levels helps assess any potential muscle injury or damage associated with obesity.
LDH (Lactate Dehydrogenase) test is included to assess cellular damage and oxidative stress. Elevated LDH levels can indicate tissue damage or inflammation, which can be associated with obesity-related complications.
Lastly, the profile incorporates a Troponin I test, a sensitive marker of cardiac muscle damage. Obesity is known to increase the risk of cardiovascular diseases, and assessing cardiac function is crucial. Elevated levels of Troponin I can indicate cardiac injury or stress.
The Obesity Profile offered by MedEX Neo Clinic provides a comprehensive evaluation of various parameters associated with obesity and its related health risks. By assessing blood glucose levels, thyroid function, lipid profile, liver enzymes, muscle enzymes, and cardiac markers, this profile helps identify metabolic abnormalities, potential organ damage, and cardiovascular risks. This comprehensive assessment enables healthcare professionals to develop personalized management strategies, guide lifestyle modifications, and effectively implement interventions to address obesity-related health concerns.